The Estée Lauder Companies (ELC) has announced a groundbreaking collaboration with biotechnology company Serpin Pharma to develop innovative anti-inflammatory ingredients for skincare applications. The partnership aims to translate Serpin's extensive anti-inflammatory research into advanced cosmetic solutions targeting skin longevity and health.
The collaboration centers on Serpin Pharma's proprietary biotech technology, which focuses on a specific portion of SERPIN (Serine Protease Inhibitors) proteins. These proteins have demonstrated remarkable ability to enhance cellular healing during inflammation by leveraging the body's natural immune response mechanisms.
Scientific Innovation in Skincare
The partnership will investigate applications of Serpin's technology in addressing three key skincare concerns: irritation, aging, and sensitivity. Scientific studies are currently in progress to evaluate the technology's potential in cosmetic formulations, with a particular focus on rapid and visible reduction of skin aging and irritation symptoms.
Carl Haney, Executive Vice President of Global Innovation and Research and Development at ELC, emphasized the transformative potential of this collaboration: "This novel technology will advance our transformative innovation agenda by pushing the boundaries of breakthrough scientific discovery. We're exploring powerful new biological pathways and cutting-edge biotech ingredients to rapidly mitigate visible skin irritation and sensitivity."
Biomimetic Approach to Skin Health
Serpin Pharma's approach is rooted in biomimicry, studying and replicating nature's solutions to inflammation and injury. Dr. Cohava Gelber, Founder, Executive Chairperson and CEO of Serpin Pharma, explained their unique perspective: "We're taking a novel approach by tapping into the body's innate mechanism for resolving inflammation. We are proud to partner with ELC to explore how our powerful biotechnology can be applied to cosmetics and skin care."
Strategic Innovation Framework
This collaboration aligns with ELC's long-standing leadership in longevity science, biotechnology, and fermentation. The company's R&D infrastructure, supported by global Innovation Centers, brings together multidisciplinary expertise spanning physics, chemistry, biology, and engineering. With 75 years of formulation experience, ELC's scientific team regularly contributes to peer-reviewed publications and partners with leading academic institutions.
The partnership represents a significant step in ELC's Beauty Reimagined strategic vision, focusing on delivering fast-to-market, innovative solutions across various beauty subcategories. By combining Serpin's breakthrough anti-inflammatory technology with ELC's cosmetic expertise, the collaboration aims to create a new generation of effective skincare solutions for consumers worldwide.
